Although SIRT1’s ability to lessen p53 activation prompted by DNA damage has the potential to aid cancer promotion, this is compensated by SIRT’s ability to promote DNA repair, so that the net impact of SIRT1 activation on cancer risk remains equivocal [177]. The gene discussed is SIRT1; the disease is cancer.